Ò©Æ·³£ÓÃÓ¢ÓïËõд1 ÏÂÔØ±¾ÎÄ

ÄÚÈÝ·¢²¼¸üÐÂʱ¼ä : 2026/3/23 14:30:44ÐÇÆÚÒ» ÏÂÃæÊÇÎÄÕµÄÈ«²¿ÄÚÈÝÇëÈÏÕæÔĶÁ¡£

¡¶GMPÓ¢Óï´Ê»ã¼°Ëõд¡·

µÚÒ»²¿·Ö

PIC/SµÄÈ«³ÆÎª£ºPharmaceutical Inspection Convention/Pharmaceutical Inspection Cooperation Scheme, PIC/S(ÖÆÒ©¼ì²é²Ý°¸), Ò©Æ·¼ì²éЭ»á(PIC/S) ,Ò²ÓÐÈ˳ÆPIC/SΪҽҩÉó²é»áÒé/ºÏ×÷¼Æ»®£¨PIC/S£©

PICµÄȨÍþ·­Ò룺ҩƷÉú²ú¼ì²éÏ໥³ÐÈϹ«Ô¼

API(Active Pharmaceutical Ingrediet) Ô­ÁÏÒ© Óֳƣº»îÐÔÒ©Îï×é·Ö AirLock ÆøÕ¢ Authorized Person ÊÚȨÈË Batch/Lot Åú´Î

Batch Number/Lot-Number ÅúºÅ£»Batch Numbering System Åú´Î±àÂëϵͳ£»

Batch Records Åú¼Ç¼£»Bulk Product ´ý°ü×°Æ·£»Calibration УÕý£»Clean area½à¾»Çø£»Consignmecnt£¨Delivery£©ÍÐÏúÒ©Æ·¡£

FDA£¨FOOD AND DRUG ADMINISTRATION£©£º£¨ÃÀ¹ú£©Ê³Æ·Ò©Æ·¹ÜÀí¾Ö IND£¨INVESTIGATIONAL NEW DRUG£©£ºÁÙ´²Ñо¿ÉêÇë

£¨Ö¸É걨½×¶Î,Ïà¶ÔÓÚNDA¶ø ÑÔ£©£»Ñо¿ÖеÄÐÂÒ©£¨Ö¸ÐÂÒ©¿ª·¢½×¶Î£¬Ïà¶ÔÓÚÐÂÒ©¶øÑÔ£¬¼´ÁÙ´²Ç°Ñо¿½áÊø£©

NDA£¨NEW DRUG APPLICATION£©£ºÐÂÒ©ÉêÇë

ANDA£¨ABBREVIATED NEW DRUG APPLICATION£©£º¼ò»¯ÐÂÒ©ÉêÇë TREATMENT IND£ºÑо¿ÖеÄÐÂÒ©ÓÃÓÚÖÎÁÆ ABBREVIATED£¨NEW£©DRUG£º¼ò»¯ÉêÇëµÄÐÂÒ© DMF£¨DRUG MASTER FILE£©£ºÒ©ÎïÖ÷Îļþ

£¨³ÖÓÐÕßΪ½÷É÷Æð¼û¶ø×¼±¸µÄ±£ÃÜ×ÊÁÏ£¬¿ÉÒÔ°üÀ¨Ò»¸ö»ò¶à¸öÈËÓÃÒ©ÎïÔÚÖÆ±¸¡¢¼Ó¹¤¡¢°ü×°ºÍÖü´æ¹ý³ÌÖÐËùÉæ¼°µÄÉ豸¡¢Éú²ú¹ý³Ì»òÎïÆ·¡£Ö»ÓÐÔÚDMF³ÖÓÐÕß»òÊÚȨ´ú±íÒÔÊÚȨÊéµÄÐÎʽÊÚȨ¸øFDA£¬FDAÔÚÉó²éIND¡¢ NDA¡¢ANDAʱ²ÅÄܲο¼ÆäÄÚÈÝ£© HOLDER£ºDMF³ÖÓÐÕß

CFR£¨CODE OF FEDERAL REGULATION£©£º£¨ÃÀ¹ú£©Áª°î·¨¹æ PANEL£º×¨¼ÒС×é

BATCH PRODUCTION£ºÅúÁ¿Éú²ú£»·ÖÅúÉú²ú BATCH PRODUCTION RECORDS£ºÉú²úÅúºÅ¼Ç¼

POST-OR PRE- MARKET SURVEILLANCE£ºÏúÊÛǰ»òÏúÊÛºó¼à¶½ INFORMED CONSENT£ºÖªÇéͬÒâ

£¨»¼Õß¶ÔÖÎÁÆ»òÊÜÊÔÕß¶ÔÒ½ÁÆÊÔÑéÁ˽âºó±íʾͬÒâ½ÓÊÜÖÎÁÆ»òÊÔÑ飩 PRESCRIPTION DRUG£º´¦·½Ò©

OTC DRUG£¨OVER¡ªTHE¡ªCOUNTER DRUG£©£º·Ç´¦·½Ò©

µÚ¶þ²¿·Ö GMPÎļþ³£¼ûËõд

ABPI Association of the British Pharmaceutical Industry ADR Adverse Drug Reaction AE Adverse Event

AIM Active Ingredient Manufacturer ANDA Abbreviated New Drug Application ANOVA Analysis of Variance ASM: Active Substance Manufacturer ATC Anatomical Therapeutic Chemical ATX Animal Test Exemption Certificate BAN British Approved Name

BIRA British Institute of Regulatory Affairs BNF British National Formulary BP British Pharmacopoeia C of A Certificate of Analysis C of S Certificate of Suitability

CENTRE FOR DRUG EVALUATION (CDE) Centre for Pharmaceutical Administration (CPA) CMS Concerned Member State CMSÿ¸ö³ÉÔ±¹ú

COS Certificate of Suitability

CPMP Committee for Proprietary Medicinal Products CRA Clinical Research Associate CRF Case Report Form

CRO Contract Research Organisation CTA Clinical Trial Application CTC Clinical Trial Certificate CTD Common Technical Document CTX Clinical Trials Exemption DDD Defined Daily Dose DGC Daily Global Comparison DIA Drug Information Association DMF Drug Master File

Drug Registration Branch (DR, Product Evaluation & Registration Division, CPA

EDQM (European Directorate for the Quality of Medicines) Å·ÖÞÁªÃËÒ©Æ·ÖÊÁ¿Ö¸µ¼Î¯Ô±»á EEA Å·ÖÞ¾­¼ÃµØÇø

EGMA European Generics Medicine Association ELA Established Licence Application

EMEA European Medicines Evaluation Agency

EMEA £¨European Agency for the Evaluation of Medicinal Products£© Å·ÖÞÁªÃËÒ©Æ·ÆÀ¼Û»ú¹¹ EP European Pharmacopoeia

EPAR European Public Assessment Reports ESRA European Society of Regulatory Affairs European Pharmacopoeia Commission Å·ÖÞÒ©µäίԱ»á FDA

FDA Food and Drug Administration final evaluation report (FER) free sale certificates (FSCs) GCP Good Clinical Practice GCPÒ©Æ·ÁÙ´²Ñо¿¹ÜÀí¹æ·¶ GLP Good Laboratory Practice

GLP Ò©Æ·ÁÙ´²Ç°°²È«ÐÔÑо¿ÖÊÁ¿¹ÜÀí¹æ·¶ GMP Good Manufacturing Practice GMP Ò©Æ·Éú²úÖÊÁ¿¹ÜÀí¹æ·¶ GSPÒ©Æ·ÏúÊÛ¹ÜÀí¹æ·¶ Health Sciences Authority (HSA)

HSA¡¯s Medicines Advisory Committee (MAC) IB Investigators Brochure

ICH International Conference for Harmonisation IDMC Independent Data-Monitoring Committee IEC Independent Ethics Committee IND Investigational New Drug

INN International Non-proprietary Name International Conference on Harmonisation (ICH) IPC In Process Control IRB Institutional Review Board LICENCE HOLDER MA Marketing Authorisation

MAA Marketing Authorisation Application MAAÉÏÊÐÉêÇë

MAH Marketing Authorisation Holder